[go: up one dir, main page]

Dose-Response Relationship, Drug

"Dose-Response Relationship, Drug" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

expand / collapse MeSH information
The relationship between the dose of an administered drug and the response of the organism to the drug.


expand / collapse Publications
This graph shows the total number of publications written about "Dose-Response Relationship, Drug" by people in this website by year, and whether "Dose-Response Relationship, Drug" was a major or minor topic of these publications.
Below are the most recent publications written about "Dose-Response Relationship, Drug" by people in Profiles.
  1. Allopregnanolone as an Adjunct Therapy to Midazolam is More Effective Than Midazolam Alone in Suppressing Soman-Induced Status Epilepticus in Male Rats. CNS Neurosci Ther. 2025 Mar; 31(3):e70215.
    View in: PubMed
  2. Biguanides antithetically regulate tumor properties by the dose-dependent mitochondrial reprogramming-driven c-Src pathway. Cell Rep Med. 2025 Feb 18; 6(2):101941.
    View in: PubMed
  3. Ocrelizumab dose selection for treatment of pediatric relapsing-remitting multiple sclerosis: results of the OPERETTA I study. J Neurol. 2025 Jan 15; 272(2):137.
    View in: PubMed
  4. Comparing the efficacy of different proton pump inhibitor dosing regimens for the treatment of gastroesophageal reflux disease: a systematic review and meta-analysis. Dis Esophagus. 2025 Jan 07; 38(1).
    View in: PubMed
  5. Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis. Blood. 2025 Jan 02; 145(1):75-84.
    View in: PubMed
  6. Predictive factors for first dose reduction and interruption of lenvatinib after beginning of the standard dose in Japanese patients with thyroid cancer. Cancer Chemother Pharmacol. 2024 Dec 19; 95(1):8.
    View in: PubMed
  7. The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression. J Affect Disord. 2025 Mar 01; 372:523-532.
    View in: PubMed
  8. High potency 3-carboxy-2-methylbenzofuran pendrin inhibitors as novel diuretics. Eur J Med Chem. 2025 Feb 05; 283:117133.
    View in: PubMed
  9. Pyrazinamide Safety, Efficacy, and Dosing for Treating Drug-Susceptible Pulmonary Tuberculosis: A Phase 3, Randomized Controlled Clinical Trial. Am J Respir Crit Care Med. 2024 Dec 01; 210(11):1358-1369.
    View in: PubMed
  10. Nanomolar activity of coumarin-3-thiosemicarbazones targeting Trypanosoma cruzi cruzain and the T. brucei cathepsin L-like protease. Eur J Med Chem. 2025 Feb 05; 283:117109.
    View in: PubMed